• Home
  • Contact
  • EnglishEnglish
    • DeutschDeutsch
Prof. Marcus Maurer
  • Personal Background
  • Publications
  • Research
Select Page
Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

by admin | Sep 29, 2020

This update on chronic urticaria (CU) focuses on the prevalence and pathogenesis of chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome measures (PROMs) for assessing CU disease activity, impact, and control, as well as future...
Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

Comparison and interpretability of the available urticaria activity scores

by mm-red | Jul 29, 2020

The urticaria activity score (UAS) is the gold standard for assessing disease activity in patients with chronic spontaneous urticaria (CSU). Two different versions, the UAS7 and UAS7TD, are currently used in clinical trials and routine care. To compare both versions...
Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema

by mm-red | Jun 25, 2020

Purpose of review: The aim of this review is to highlight the most important, clinically relevant patient-reported outcome (PRO) measures for chronic spontaneous urticaria and recurrent angioedema. Recent findings: The use of PROs becomes increasingly important in...
Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen

by mm-red | Jun 23, 2020

Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema

by mm-red | Jun 21, 2020

Hereditary angioedema (HAE) is a group of rare, potentially life-threatening, and fre- quently debilitating diseases characterized by recurrent, and often with an unpredictable onset, of swelling attacks. HAE is heterogeneous, with considerable differences between its...
« Older Entries

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Privacy Policy
    • Imprint
    • Cookie Policy (EU)
    © 2020 Marcus Maurer
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}